Best practices for naming, receiving, and managing cells in culture
Abstract
One of the first considerations in using an existing cell line or establishing a new a cell line is the detailed proactive planning of all phases of the cell line management. It is necessary to have a well-trained practitioner in best practices in cell culture who has experience in receiving a new cell line into the laboratory, the correct and appropriate use of a cell line name, the preparation of cell banks, microscopic observation of cells in culture, growth optimization, cell count, cell subcultivation, as well as detailed protocols on how to expand and store cells. Indeed, the practitioner should best manage all activities of cell culture by ensuring that the appropriate certified facilities, equipment, and validated supplies and reagents are in place.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is no universally accepted naming convention for all cell lines, but some fields, such as PSCs, have published standards to systematically create unique cell line identifiers.
“Although there is no universally accepted naming convention for all cell lines, some fields, such as PSCs, have published standards to systematically create unique cell line identifiers (Kurtz et al., 2018; Reid, 2017).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Reid, 2017
Cites
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374 · see citing works
Yu, H., Cook, T. J., & Sinko, P. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012150405949 · Cited by 133 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100 · see citing works
Misspellings or “miscellings”—Non‐verifiable and unknown cell lines in cancer research publications
Oste, D. J., Pathmendra, P., Richardson, R. A. K., Johnson, G., Ao, Y., Arya, M. D., Enochs, N. R., Hussein, M., Kang, J., Lee, A., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34995 · Cited by 18 · see citing works
- Authors
- Reid, Y. A.
- Venue
- In Vitro Cellular & Developmental Biology - Animal
- Published
- 2017-10
- Volume
- 53
- Issue
- 9
- Pages
- 761-774
- ISSN
- 1071-2690
- 1543-706X
- Cited by
- 11
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review